THE NOCTURIA IMPACT DIARY- A NEW VALIDATED SELF-REPORTED IMPACT ASSESSMENT TOOL

Published Sep 26, 2014
Copenhagen, Denmark - Many people experience waking up several times a night to go to the toilet – a condition called nocturia. Some people fall right back to sleep and are not bothered at all, but others experience a chronic, cumulative interference with sleep with a large impact on quality of life. As a result, researchers from Denmark and the United States developed the Nocturia Impact Diary © to assess the potential impact of nocturia on quality of life and the benefit of treatment. The Nocturia Impact Diary is a questionnaire that includes questions on energy, productivity, mood, low sleep quality, as well as social self-limitations. The development of this questionnaire followed three steps recommended by the FDA as well as the ISPOR PRO guidelines (concepts and assessment): (1) development of a comprehensive concept pool compiled to reflect the important aspects of nocturia experienced by patients; (2) content validity explored in a series of focus group interviews; and (3) psychometric testing to assess the validity, reliability and sensitivity of the diary in a clinical trial setting. “The Nocturia Impact (NI) Diary is the first nocturia impact assessment tool developed in close dialogue with the FDA and in accordance with new patient-reported outcome (PRO) validation guidelines,” said author Dr. Tove Holm-Larsen, PhD, Managing Director of Pharma Evidence and external lecturer at the University of Copenhagen, Denmark.  “The NI Diary has high validity, reliability and sensitivity. It captures the real-life consequences of nocturia and its treatment and should be used in conjunction with the 3-Day Voiding Diary, commonly used for diagnosis of urological diseases.” The full study, “The Nocturia Impact Diary: A Self-Reported Impact Measure to Complement the Voiding Diary,” is published in Value in Health.

Related Stories

How to Measure Meaningful Benefit for Patients With Rare Diseases

Oct 28, 2026

Value in Health announced the publication of a themed section examining new approaches to measuring meaningful change for patients with rare diseases.

New Research and Policy Priorities Chart a Broader Role for HEOR

Oct 15, 2026

Value in Health announced today the publication of a new commentary that calls for expanding the role of health economics and outcomes research (HEOR) and increasing its impact on real-world decision making.

New Study Sheds Light on QALY and Disability Debate

Sep 28, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a study showing no evidence that the use of quality-adjusted life years (QALYs) inherently disadvantages people with disabilities.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×